Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342).

Castillo-Mancilla, Jose R

Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342). [electronic resource] - The Journal of antimicrobial chemotherapy 06 2016 - 1609-18 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1460-2091

10.1093/jac/dkw005 doi


Adult
Anti-HIV Agents--administration & dosage
Atazanavir Sulfate--administration & dosage
Female
HIV Infections--drug therapy
HIV Protease Inhibitors
Humans
Male
Middle Aged
Peru
Pharmacogenetics
Polymorphism, Genetic
Retrospective Studies
South Africa
United States
Young Adult